VP/Chief Accounting Officer
Mon, Sep 16, 2024
Sep 16
192 shares @ $36.21
Decreased holdings by -0.50%
20th largest trade (out of 55)
Positive 90D History
Trade made by an officer
67% win rate · +23.6% median edge vs SPY (6 trades, 90-day · small sample)
Price 28% below 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology